Last $70.57 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:04 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for astrazeneca plc-spons adr (AZN)

Although debt as a percent of total capital increased at AstraZeneca PLC over the last fiscal year to 30.85%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 79.57 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 141.10 days.
Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Cash and Equivalents11,068.07,571.07,701.09,217.0
Trading Asset Securities20.
TOTAL CASH AND SHORT TERM INVESTMENTS12,195.011,523.07,776.09,294.0
Other Receivables3,714.02,293.01,638.01,288.0
TOTAL RECEIVABLES9,961.08,923.07,334.06,802.0
Prepaid Expenses929.0887.01,098.01,571.0
TOTAL CURRENT ASSETS25,131.023,506.019,048.020,335.0
Gross Property Plant and Equipment15,583.015,310.015,071.014,907.0
Accumulated Depreciation-8,626.0-8,885.0-8,982.0-9,089.0
NET PROPERTY PLANT AND EQUIPMENT6,957.06,425.06,089.05,818.0
Deferred Tax Assets, Long Term1,475.01,514.01,111.01,205.0
Other Long-Term Assets164.0153.0579.02,163.0
TOTAL ASSETS56,127.052,830.053,534.055,899.0
Accrued Expenses5,459.06,102.05,917.06,666.0
Short-Term Borrowings125.0221.0879.0992.0
Current Portion of Capital Lease Obligations----22.030.0
Current Income Taxes Payable6,898.03,390.02,862.03,076.0
Other Current Liabilities, Total2,040.02,115.01,774.02,022.0
TOTAL CURRENT LIABILITIES16,787.015,752.013,903.016,051.0
Long-Term Debt9,097.07,338.09,347.08,516.0
Capital Leases----62.072.0
Pension & Other Post-Retirement Benefits2,472.02,680.02,271.02,261.0
Deferred Tax Liability Non-Current3,145.02,735.02,576.02,827.0
Other Non-Current Liabilities1,216.0859.01,429.02,919.0
Common Stock352.0323.0312.0315.0
Additional Paid in Capital2,672.03,078.03,504.03,983.0
Retained Earnings18,339.016,128.016,054.015,178.0
TOTAL COMMON EQUITY23,213.023,240.023,731.023,224.0
TOTAL EQUITY23,410.023,466.023,946.023,253.0
TOTAL LIABILITIES AND EQUITY56,127.052,830.053,534.055,899.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:US $70.57 USD 0.00

AZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $62.83 USD 0.00
Biogen Idec Inc $362.44 USD 0.00
Celgene Corp $124.12 USD 0.00
Eli Lilly & Co $72.11 USD 0.00
Novo Nordisk A/S kr298.80 DKK +1.60
View Industry Companies

Industry Analysis


Industry Average

Valuation AZN Industry Range
Price/Earnings 87.0x
Price/Sales 3.4x
Price/Book 4.4x
Price/Cash Flow 87.0x
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at